Insider Profile
Groleau, Melanie
$GUD
1
Companies Filed At
5
Open-Market Buys (2yr)
$413K
Buy Value (2yr, open-market)
Jun 10, 2026
Most Recent Trade
Currently Accumulating Companies this insider is net-buying on the open market over the last 90 days
$GUD 59
Knight Therapeutics Inc.
$413K · 5 buys
Last buy Jun 10, 2026
Date Company Role Nature Dir. Shares Price Value Score
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 4,390 $6.21 $27K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Buy 4,390 $6.21 $27K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Open Market Buy 4,390 $9.25 $41K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 4,039 $5.72 $23K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Buy 4,039 $5.72 $23K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Open Market Buy 4,039 $9.25 $37K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 4,039 $5.72 $23K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 1,709 $7.02 $12K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Buy 1,709 $7.02 $12K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Open Market Buy 1,709 $9.25 $16K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 5,129 $7.02 $36K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Buy 5,129 $7.02 $36K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Open Market Buy 5,129 $9.25 $47K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Sell 29,403 $7.73 $227K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Exercise Buy 29,403 $7.73 $227K 59
Jun 10, 2026 $GUD
Knight Therapeutics Inc.
— Open Market Buy 29,403 $9.25 $272K 59
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.